Belluscura tries on DTC business
By HME News Staff
Updated 9:31 AM CDT, Wed October 25, 2023
LONDON, PLANO, Texas, and SHENZHEN, China – Belluscura, a medical device developer focused on lightweight and portable oxygen technology, says early results on a two-month-old direct to consumer program for its X-PLOR device have exceeded initial expectations. The company has launched a three-pronged direct sales, leasing and short-term rental program for the device that has been well received by customers. "I am very excited about the new direct-to consumer sales program,” said Bob Fary, senior vice president of sales and marketing. “We have identified a potentially significant sales opportunity that not only benefits the company but underrepresented patients, as well." Belluscura sees the DTC program expanding significantly with the launch of the DISCOV-R portable oxygen concentrator. Earlier this month, Belluscura announced that it reached an agreement with TMT Acquisitions, a London-based acquisition vehicle in the technology, media and telecommunications sector, to help grow its portable oxygen concentrator business globally.
Comments